
|Articles|January 1, 2003
Tried and (Still) True
Author(s)Andrew Bowser
New York - Even as biologic therapies become available, there will still be a place for acitretin, methotrexate and cyclosporin-based treatment protocols, according to Mark Lebwohl, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease
4
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
5


















